Management of Hypoglycemia in Patients with Type 2 Diabetes

Volume 1 - Issue 4

Jeff Unger*

Received: September 19, 2018;   Published: September 24, 2018

DOI: 10.32474/ADO.2018.01.000116

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

The rate limiting step of intensive diabetes management for patients with diabetes is treatment induced hypoglycemia. Thus, hypoglycemia remains a significant barrier in optimizing glycemic control and reducing long-term diabetes related complications including cardiovascular death, stroke, and all cause-mortality [1]. Cardiovascular (CV) events are the leading cause of death among patients with diabetes.

Introduction| Definition of Hypoglycemia| Case Introduction-Tammy| Case Continues| Addressing Glycemic Variability Using Novel Insulin Formulations| Insulin Glargine U-300| Insulin Degludec| Targeting Hypoglycemia Prevention in High Risk Patients| Conclusion| References|